Extending the clinical spectrum of SPG3A mutations to a very severe and very early complicated phenotype - PubMed (original) (raw)

Case Reports

Extending the clinical spectrum of SPG3A mutations to a very severe and very early complicated phenotype

J Haberlová et al. J Neurol. 2008 Jun.

No abstract available

PubMed Disclaimer

Similar articles

• Novel SPG3A and SPG4 mutations in two patients with Silver syndrome.
  Salameh JS, Shenoy AM, David WS. Salameh JS, et al. J Clin Neuromuscul Dis. 2009 Sep;11(1):57-9. doi: 10.1097/CND.0b013e3181ae3c06. J Clin Neuromuscul Dis. 2009. PMID: 19730024
• SPG3A is the most frequent cause of hereditary spastic paraplegia with onset before age 10 years.
  Namekawa M, Ribai P, Nelson I, Forlani S, Fellmann F, Goizet C, Depienne C, Stevanin G, Ruberg M, Dürr A, Brice A. Namekawa M, et al. Neurology. 2006 Jan 10;66(1):112-4. doi: 10.1212/01.wnl.0000191390.20564.8e. Neurology. 2006. PMID: 16401858
• Complex phenotype in an Italian family with a novel mutation in SPG3A.
  de Leva MF, Filla A, Criscuolo C, Tessa A, Pappatà S, Quarantelli M, Bilo L, Peluso S, Antenora A, Longo D, Santorelli FM, De Michele G. de Leva MF, et al. J Neurol. 2010 Mar;257(3):328-31. doi: 10.1007/s00415-009-5311-3. Epub 2009 Sep 19. J Neurol. 2010. PMID: 19768483
• [Classification of hereditary spastic paraplegia (HSP)].
  Utsumi H, Yuasa T. Utsumi H, et al. No To Shinkei. 2003 Sep;55(9):739-47. No To Shinkei. 2003. PMID: 14571835 Review. Japanese. No abstract available.
• Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms.
  Salinas S, Proukakis C, Crosby A, Warner TT. Salinas S, et al. Lancet Neurol. 2008 Dec;7(12):1127-38. doi: 10.1016/S1474-4422(08)70258-8. Lancet Neurol. 2008. PMID: 19007737 Review.

Cited by

• Patients with complex and very-early-onset ATL1-related spastic paraplegia offer insights on genotype/phenotype correlations and support for autosomal recessive forms of SPG3A.
  Hamamie-Chaar A, Renaud M, Gençpinar P, Bruel AL, Philippe C, Maraval J, Racine C, Hadouiri N, Lambert L, Schmitt E, Banneau G, Hocquel A, Thauvin-Robinet C, Faivre L, Thomas Q. Hamamie-Chaar A, et al. J Neurol. 2024 Sep;271(9):6343-6348. doi: 10.1007/s00415-024-12565-0. Epub 2024 Jul 13. J Neurol. 2024. PMID: 39003427 Free PMC article.
• Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.
  Fink JK. Fink JK. Acta Neuropathol. 2013 Sep;126(3):307-28. doi: 10.1007/s00401-013-1115-8. Epub 2013 Jul 30. Acta Neuropathol. 2013. PMID: 23897027 Free PMC article. Review.
• De novo variants cause complex symptoms in HSP-ATL1 (SPG3A) and uncover genotype-phenotype correlations.
  Alecu JE, Saffari A, Jordan C, Srivastava S, Blackstone C, Ebrahimi-Fakhari D. Alecu JE, et al. Hum Mol Genet. 2023 Jan 1;32(1):93-103. doi: 10.1093/hmg/ddac182. Hum Mol Genet. 2023. PMID: 35925862 Free PMC article.
• Clinical features and genotype-phenotype correlation analysis in patients with ATL1 mutations: A literature reanalysis.
  Zhao GH, Liu XM. Zhao GH, et al. Transl Neurodegener. 2017 Apr 4;6:9. doi: 10.1186/s40035-017-0079-3. eCollection 2017. Transl Neurodegener. 2017. PMID: 28396731 Free PMC article.

References

1. 1. Nucleic Acids Res. 2005 Jan 1;33(Database issue):D192-6 - PubMed
2. 1. Neurology. 2003 Aug 26;61(4):580-1 - PubMed
3. 1. Arch Neurol. 2007 May;64(5):706-13 - PubMed
4. 1. J Neurol. 2005 Aug;252(8):901-3 - PubMed
5. 1. Nat Genet. 2001 Nov;29(3):326-31 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Springer